IQVIA Holdings (IQV)

Its Research & Development Solutions business helps biopharmaceutical companies plan and run clinical programmes. Services can cover trial design, patient recruitment, site selection and management, clinical monitoring, laboratory and testing support, real-world evidence studies, and assistance with regulatory processes. By outsourcing this work to IQVIA, drug developers can access global infrastructure, therapeutic expertise, and operational scale without building every capability internally.

IQVIA also supports companies after and around product launch through its technology and commercial services. These offerings include healthcare analytics, market access support, sales and medical outsourcing, and software platforms used to understand treatment patterns, physician behaviour, patient populations, and product performance. The company’s data assets and analytical tools are used by pharmaceutical manufacturers, biotechnology companies, medical technology firms, payers, providers, and public-sector organisations.

The company’s role is tied closely to the complexity of modern healthcare. Drug development requires larger data sets, more specialised trial designs, and stronger evidence of safety, efficacy, value, and real-world outcomes. IQVIA serves that demand by combining contract research capabilities with healthcare intelligence, making it a key service provider for companies seeking to develop, approve, and commercialise medicines globally.